glp-1 agonists and pancreatitis The pancreatic extrapancreatic effect of GLP-1. GLP-1, glucagon GLP-1 Agonists and Pancreatitis Risk

Description

The genetics of obesity: From discovery to biology

doi: 10.1001/jama.2019.22360 57 JankovicJTanEK

For example, a 2024 paper in Anesthesiology noted: Is there any evidence that the risk of gastroparesis or gastric contents is altered by holding the daily or weekly dose

3 Note that this consensus algorithm is a guide and that the clinical management of T2DM should always incorporate the patients unique goals, comorbidities, individual response to therapy, and other factors that may introduce unwanted drug interactions or contraindications to a particular therapy or therapies

As well as physical health risks, the stigma attached to excess body weight and obesity can have adverse psychosocial consequences and lower the quality of life